© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Eduardo Richardet, MD, PhD
Articles
Uracil/Tegafur Plus Oral Calcium Folinate in Advanced Breast Cancer
July 01, 1999
ByEduardo Richardet, MD, PhD|Cecilia Pedraza, MD|Elizabeth Mickiewicz, MD|Guillermo Lerzo, MD|Federico Coppola, MD|Alicia Elli, MD|Graciela Uranga, MD|Silvia Jovtis, MD|Mario Bruno, MD|Monica Ventriglia, MD|Maria Andrea Cuevas, MD|Ana Maria Alvarez, MD|Luis Alberto Suarez, MD|Luis Fein, MDUracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may